English
简体中文
Total: £ 56.28
Published Date: 2025-07-21 | Pages: 97 | Tables: 91 | Pharma & Healthcare
The global market for Ketoprofen Transdermal Patch was valued at US$ 378 million in the year 2024 and is projected to reach a revised size of US$ 522 million by 2031, growing at a CAGR of 4.7% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ketoprofen Transdermal Patch competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Ketoprofen transdermal patch is a topical non-steroidal anti-inflammatory drug (NSAID) formulation designed to deliver ketoprofen directly through the skin to reduce localized pain and inflammation. It is commonly used for conditions such as arthritis, muscle strain, back pain, and sports injuries. Compared with oral NSAIDs, the patch minimizes systemic exposure and side effects, particularly gastrointestinal irritation. The patch provides sustained drug release over 12 to 24 hours and is appreciated for its convenience, better patient compliance, and localized action. Ketoprofen patches are available in both prescription and over-the-counter forms in many countries.
Growth is mainly driven by the aging population, rising demand for non-opioid pain relief, and increasing acceptance of transdermal delivery systems. Innovations in hydrogel and matrix patch technologies are improving comfort and drug release profiles, contributing to market expansion. Regulatory policies, reimbursement structures, and the competitive presence of alternative NSAID patches such as diclofenac and flurbiprofen can impact growth dynamics across regions.
Regional breakdown:
Japan: One of the most mature markets for ketoprofen patches, where products are widely used and often reimbursed. Local companies such as Hisamitsu Pharmaceutical and Teikoku Seiyaku dominate this segment. High elderly population and preference for non-oral analgesics support stable demand.
Europe: Moderate to high market penetration, especially in countries like France, Italy, and Spain. Ketoprofen is a well-accepted NSAID in these markets, and transdermal formulations are commonly prescribed for chronic musculoskeletal conditions.
China and other parts of Asia: A fast-growing region. China’s domestic manufacturers have introduced generic versions, and increasing acceptance in hospitals and retail pharmacies is driving adoption. Southeast Asia is showing rising demand due to expansion in pain management and rehabilitation services.
North America: Limited presence due to regulatory restrictions and preference for other NSAIDs such as diclofenac. However, with growing interest in non-opioid therapies, the market may see slow but steady growth.
Rest of world: Latin America and the Middle East are emerging markets for ketoprofen patches, though penetration is still low. Growth is expected as awareness increases and healthcare access improves.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ketoprofen Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketoprofen Transdermal Patch.
The Ketoprofen Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ketoprofen Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, by Prescription and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketoprofen Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Prescription and by regions.
By Company
Hisamitsu Pharmaceutical
Teikoku Seiyaku
Handok
Kyorin Pharmaceutical
Yutoku Yakuhin
Nichi-Iko Pharmaceutical
Abiogen Pharma
Sanwa Kagaku Kenkyusho
Wooshin Medics
Jeil Pharmaceutical
Emcure Pharmaceuticals
Towa Pharmaceutical
Nihon Generic
Guizhou Liansheng Pharmaceutical
Jiudian Pharmaceutical
Segment by Type
Hydrogel Patch
Polymer Matrix Controlled-Release Patch
Self-Adhesive Nonwoven Patch
Segment by Prescription
Rx
OTC
Segment by Application
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ketoprofen Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ketoprofen Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Ketoprofen Transdermal Patch Market Overview
1.1 Product Definition
1.2 Ketoprofen Transdermal Patch by Type
1.2.1 Global Ketoprofen Transdermal Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hydrogel Patch
1.2.3 Polymer Matrix Controlled-Release Patch
1.2.4 Self-Adhesive Nonwoven Patch
1.3 Ketoprofen Transdermal Patch by Prescription
1.3.1 Global Ketoprofen Transdermal Patch Market Value Comparison by Prescription: 2024 VS 2031
1.3.2 Rx
1.3.3 OTC
1.4 Ketoprofen Transdermal Patch by Application
1.4.1 Global Ketoprofen Transdermal Patch Market Value by Application (2024 VS 2031)
1.4.2 Hospitals and Clinics
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Ketoprofen Transdermal Patch Market Size Estimates and Forecasts
1.5.1 Global Ketoprofen Transdermal Patch Revenue 2020-2031
1.5.2 Global Ketoprofen Transdermal Patch Sales 2020-2031
1.5.3 Global Ketoprofen Transdermal Patch Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Ketoprofen Transdermal Patch Market Competition by Manufacturers
2.1 Global Ketoprofen Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ketoprofen Transdermal Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ketoprofen Transdermal Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ketoprofen Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ketoprofen Transdermal Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ketoprofen Transdermal Patch, Product Type & Application
2.7 Global Key Manufacturers of Ketoprofen Transdermal Patch, Date of Enter into This Industry
2.8 Global Ketoprofen Transdermal Patch Market Competitive Situation and Trends
2.8.1 Global Ketoprofen Transdermal Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ketoprofen Transdermal Patch Players Market Share by Revenue
2.8.3 Global Ketoprofen Transdermal Patch Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ketoprofen Transdermal Patch Market Scenario by Region
3.1 Global Ketoprofen Transdermal Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ketoprofen Transdermal Patch Sales by Region: 2020-2031
3.2.1 Global Ketoprofen Transdermal Patch Sales by Region: 2020-2025
3.2.2 Global Ketoprofen Transdermal Patch Sales by Region: 2026-2031
3.3 Global Ketoprofen Transdermal Patch Revenue by Region: 2020-2031
3.3.1 Global Ketoprofen Transdermal Patch Revenue by Region: 2020-2025
3.3.2 Global Ketoprofen Transdermal Patch Revenue by Region: 2026-2031
3.4 North America Ketoprofen Transdermal Patch Market Facts & Figures by Country
3.4.1 North America Ketoprofen Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ketoprofen Transdermal Patch Sales by Country (2020-2031)
3.4.3 North America Ketoprofen Transdermal Patch Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ketoprofen Transdermal Patch Market Facts & Figures by Country
3.5.1 Europe Ketoprofen Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ketoprofen Transdermal Patch Sales by Country (2020-2031)
3.5.3 Europe Ketoprofen Transdermal Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ketoprofen Transdermal Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Ketoprofen Transdermal Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ketoprofen Transdermal Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Ketoprofen Transdermal Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ketoprofen Transdermal Patch Market Facts & Figures by Country
3.7.1 Latin America Ketoprofen Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ketoprofen Transdermal Patch Sales by Country (2020-2031)
3.7.3 Latin America Ketoprofen Transdermal Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Ketoprofen Transdermal Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Ketoprofen Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ketoprofen Transdermal Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ketoprofen Transdermal Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ketoprofen Transdermal Patch Sales by Type (2020-2031)
4.1.1 Global Ketoprofen Transdermal Patch Sales by Type (2020-2025)
4.1.2 Global Ketoprofen Transdermal Patch Sales by Type (2026-2031)
4.1.3 Global Ketoprofen Transdermal Patch Sales Market Share by Type (2020-2031)
4.2 Global Ketoprofen Transdermal Patch Revenue by Type (2020-2031)
4.2.1 Global Ketoprofen Transdermal Patch Revenue by Type (2020-2025)
4.2.2 Global Ketoprofen Transdermal Patch Revenue by Type (2026-2031)
4.2.3 Global Ketoprofen Transdermal Patch Revenue Market Share by Type (2020-2031)
4.3 Global Ketoprofen Transdermal Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ketoprofen Transdermal Patch Sales by Application (2020-2031)
5.1.1 Global Ketoprofen Transdermal Patch Sales by Application (2020-2025)
5.1.2 Global Ketoprofen Transdermal Patch Sales by Application (2026-2031)
5.1.3 Global Ketoprofen Transdermal Patch Sales Market Share by Application (2020-2031)
5.2 Global Ketoprofen Transdermal Patch Revenue by Application (2020-2031)
5.2.1 Global Ketoprofen Transdermal Patch Revenue by Application (2020-2025)
5.2.2 Global Ketoprofen Transdermal Patch Revenue by Application (2026-2031)
5.2.3 Global Ketoprofen Transdermal Patch Revenue Market Share by Application (2020-2031)
5.3 Global Ketoprofen Transdermal Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Company Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu Pharmaceutical Ketoprofen Transdermal Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Teikoku Seiyaku
6.2.1 Teikoku Seiyaku Company Information
6.2.2 Teikoku Seiyaku Description and Business Overview
6.2.3 Teikoku Seiyaku Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teikoku Seiyaku Ketoprofen Transdermal Patch Product Portfolio
6.2.5 Teikoku Seiyaku Recent Developments/Updates
6.3 Handok
6.3.1 Handok Company Information
6.3.2 Handok Description and Business Overview
6.3.3 Handok Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Handok Ketoprofen Transdermal Patch Product Portfolio
6.3.5 Handok Recent Developments/Updates
6.4 Kyorin Pharmaceutical
6.4.1 Kyorin Pharmaceutical Company Information
6.4.2 Kyorin Pharmaceutical Description and Business Overview
6.4.3 Kyorin Pharmaceutical Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kyorin Pharmaceutical Ketoprofen Transdermal Patch Product Portfolio
6.4.5 Kyorin Pharmaceutical Recent Developments/Updates
6.5 Yutoku Yakuhin
6.5.1 Yutoku Yakuhin Company Information
6.5.2 Yutoku Yakuhin Description and Business Overview
6.5.3 Yutoku Yakuhin Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Yutoku Yakuhin Ketoprofen Transdermal Patch Product Portfolio
6.5.5 Yutoku Yakuhin Recent Developments/Updates
6.6 Nichi-Iko Pharmaceutical
6.6.1 Nichi-Iko Pharmaceutical Company Information
6.6.2 Nichi-Iko Pharmaceutical Description and Business Overview
6.6.3 Nichi-Iko Pharmaceutical Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nichi-Iko Pharmaceutical Ketoprofen Transdermal Patch Product Portfolio
6.6.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.7 Abiogen Pharma
6.7.1 Abiogen Pharma Company Information
6.7.2 Abiogen Pharma Description and Business Overview
6.7.3 Abiogen Pharma Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abiogen Pharma Ketoprofen Transdermal Patch Product Portfolio
6.7.5 Abiogen Pharma Recent Developments/Updates
6.8 Sanwa Kagaku Kenkyusho
6.8.1 Sanwa Kagaku Kenkyusho Company Information
6.8.2 Sanwa Kagaku Kenkyusho Description and Business Overview
6.8.3 Sanwa Kagaku Kenkyusho Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanwa Kagaku Kenkyusho Ketoprofen Transdermal Patch Product Portfolio
6.8.5 Sanwa Kagaku Kenkyusho Recent Developments/Updates
6.9 Wooshin Medics
6.9.1 Wooshin Medics Company Information
6.9.2 Wooshin Medics Description and Business Overview
6.9.3 Wooshin Medics Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Wooshin Medics Ketoprofen Transdermal Patch Product Portfolio
6.9.5 Wooshin Medics Recent Developments/Updates
6.10 Jeil Pharmaceutical
6.10.1 Jeil Pharmaceutical Company Information
6.10.2 Jeil Pharmaceutical Description and Business Overview
6.10.3 Jeil Pharmaceutical Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jeil Pharmaceutical Ketoprofen Transdermal Patch Product Portfolio
6.10.5 Jeil Pharmaceutical Recent Developments/Updates
6.11 Emcure Pharmaceuticals
6.11.1 Emcure Pharmaceuticals Company Information
6.11.2 Emcure Pharmaceuticals Description and Business Overview
6.11.3 Emcure Pharmaceuticals Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Emcure Pharmaceuticals Ketoprofen Transdermal Patch Product Portfolio
6.11.5 Emcure Pharmaceuticals Recent Developments/Updates
6.12 Towa Pharmaceutical
6.12.1 Towa Pharmaceutical Company Information
6.12.2 Towa Pharmaceutical Description and Business Overview
6.12.3 Towa Pharmaceutical Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Towa Pharmaceutical Ketoprofen Transdermal Patch Product Portfolio
6.12.5 Towa Pharmaceutical Recent Developments/Updates
6.13 Nihon Generic
6.13.1 Nihon Generic Company Information
6.13.2 Nihon Generic Description and Business Overview
6.13.3 Nihon Generic Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nihon Generic Ketoprofen Transdermal Patch Product Portfolio
6.13.5 Nihon Generic Recent Developments/Updates
6.14 Guizhou Liansheng Pharmaceutical
6.14.1 Guizhou Liansheng Pharmaceutical Company Information
6.14.2 Guizhou Liansheng Pharmaceutical Description and Business Overview
6.14.3 Guizhou Liansheng Pharmaceutical Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Guizhou Liansheng Pharmaceutical Ketoprofen Transdermal Patch Product Portfolio
6.14.5 Guizhou Liansheng Pharmaceutical Recent Developments/Updates
6.15 Jiudian Pharmaceutical
6.15.1 Jiudian Pharmaceutical Company Information
6.15.2 Jiudian Pharmaceutical Description and Business Overview
6.15.3 Jiudian Pharmaceutical Ketoprofen Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jiudian Pharmaceutical Ketoprofen Transdermal Patch Product Portfolio
6.15.5 Jiudian Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ketoprofen Transdermal Patch Industry Chain Analysis
7.2 Ketoprofen Transdermal Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ketoprofen Transdermal Patch Production Mode & Process Analysis
7.4 Ketoprofen Transdermal Patch Sales and Marketing
7.4.1 Ketoprofen Transdermal Patch Sales Channels
7.4.2 Ketoprofen Transdermal Patch Distributors
7.5 Ketoprofen Transdermal Patch Customer Analysis
8 Ketoprofen Transdermal Patch Market Dynamics
8.1 Ketoprofen Transdermal Patch Industry Trends
8.2 Ketoprofen Transdermal Patch Market Drivers
8.3 Ketoprofen Transdermal Patch Market Challenges
8.4 Ketoprofen Transdermal Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Ketoprofen Transdermal Patch Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Ketoprofen Transdermal Patch Market Value by Prescription, (US$ Million) & (2024 VS 2031)
Table 3. Global Ketoprofen Transdermal Patch Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Ketoprofen Transdermal Patch Market Competitive Situation by Manufacturers in 2024
Table 5. Global Ketoprofen Transdermal Patch Sales (K Dose) of Key Manufacturers (2020-2025)
Table 6. Global Ketoprofen Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Ketoprofen Transdermal Patch Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Ketoprofen Transdermal Patch Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Ketoprofen Transdermal Patch Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Ketoprofen Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Ketoprofen Transdermal Patch, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Ketoprofen Transdermal Patch, Product Type & Application
Table 13. Global Key Manufacturers of Ketoprofen Transdermal Patch, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Ketoprofen Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketoprofen Transdermal Patch as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Ketoprofen Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Ketoprofen Transdermal Patch Sales by Region (2020-2025) & (K Dose)
Table 19. Global Ketoprofen Transdermal Patch Sales Market Share by Region (2020-2025)
Table 20. Global Ketoprofen Transdermal Patch Sales by Region (2026-2031) & (K Dose)
Table 21. Global Ketoprofen Transdermal Patch Sales Market Share by Region (2026-2031)
Table 22. Global Ketoprofen Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Ketoprofen Transdermal Patch Revenue Market Share by Region (2020-2025)
Table 24. Global Ketoprofen Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Ketoprofen Transdermal Patch Revenue Market Share by Region (2026-2031)
Table 26. North America Ketoprofen Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Ketoprofen Transdermal Patch Sales by Country (2020-2025) & (K Dose)
Table 28. North America Ketoprofen Transdermal Patch Sales by Country (2026-2031) & (K Dose)
Table 29. North America Ketoprofen Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Ketoprofen Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Ketoprofen Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Ketoprofen Transdermal Patch Sales by Country (2020-2025) & (K Dose)
Table 33. Europe Ketoprofen Transdermal Patch Sales by Country (2026-2031) & (K Dose)
Table 34. Europe Ketoprofen Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Ketoprofen Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Ketoprofen Transdermal Patch Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Ketoprofen Transdermal Patch Sales by Region (2020-2025) & (K Dose)
Table 38. Asia Pacific Ketoprofen Transdermal Patch Sales by Region (2026-2031) & (K Dose)
Table 39. Asia Pacific Ketoprofen Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Ketoprofen Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Ketoprofen Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Ketoprofen Transdermal Patch Sales by Country (2020-2025) & (K Dose)
Table 43. Latin America Ketoprofen Transdermal Patch Sales by Country (2026-2031) & (K Dose)
Table 44. Latin America Ketoprofen Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Ketoprofen Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Ketoprofen Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Ketoprofen Transdermal Patch Sales by Country (2020-2025) & (K Dose)
Table 48. Middle East and Africa Ketoprofen Transdermal Patch Sales by Country (2026-2031) & (K Dose)
Table 49. Middle East and Africa Ketoprofen Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Ketoprofen Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Ketoprofen Transdermal Patch Sales (K Dose) by Type (2020-2025)
Table 52. Global Ketoprofen Transdermal Patch Sales (K Dose) by Type (2026-2031)
Table 53. Global Ketoprofen Transdermal Patch Sales Market Share by Type (2020-2025)
Table 54. Global Ketoprofen Transdermal Patch Sales Market Share by Type (2026-2031)
Table 55. Global Ketoprofen Transdermal Patch Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Ketoprofen Transdermal Patch Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Ketoprofen Transdermal Patch Revenue Market Share by Type (2020-2025)
Table 58. Global Ketoprofen Transdermal Patch Revenue Market Share by Type (2026-2031)
Table 59. Global Ketoprofen Transdermal Patch Price (US$/Dose) by Type (2020-2025)
Table 60. Global Ketoprofen Transdermal Patch Price (US$/Dose) by Type (2026-2031)
Table 61. Global Ketoprofen Transdermal Patch Sales (K Dose) by Application (2020-2025)
Table 62. Global Ketoprofen Transdermal Patch Sales (K Dose) by Application (2026-2031)
Table 63. Global Ketoprofen Transdermal Patch Sales Market Share by Application (2020-2025)
Table 64. Global Ketoprofen Transdermal Patch Sales Market Share by Application (2026-2031)
Table 65. Global Ketoprofen Transdermal Patch Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Ketoprofen Transdermal Patch Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Ketoprofen Transdermal Patch Revenue Market Share by Application (2020-2025)
Table 68. Global Ketoprofen Transdermal Patch Revenue Market Share by Application (2026-2031)
Table 69. Global Ketoprofen Transdermal Patch Price (US$/Dose) by Application (2020-2025)
Table 70. Global Ketoprofen Transdermal Patch Price (US$/Dose) by Application (2026-2031)
Table 71. Hisamitsu Pharmaceutical Company Information
Table 72. Hisamitsu Pharmaceutical Description and Business Overview
Table 73. Hisamitsu Pharmaceutical Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 74. Hisamitsu Pharmaceutical Ketoprofen Transdermal Patch Product
Table 75. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 76. Teikoku Seiyaku Company Information
Table 77. Teikoku Seiyaku Description and Business Overview
Table 78. Teikoku Seiyaku Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 79. Teikoku Seiyaku Ketoprofen Transdermal Patch Product
Table 80. Teikoku Seiyaku Recent Developments/Updates
Table 81. Handok Company Information
Table 82. Handok Description and Business Overview
Table 83. Handok Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 84. Handok Ketoprofen Transdermal Patch Product
Table 85. Handok Recent Developments/Updates
Table 86. Kyorin Pharmaceutical Company Information
Table 87. Kyorin Pharmaceutical Description and Business Overview
Table 88. Kyorin Pharmaceutical Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 89. Kyorin Pharmaceutical Ketoprofen Transdermal Patch Product
Table 90. Kyorin Pharmaceutical Recent Developments/Updates
Table 91. Yutoku Yakuhin Company Information
Table 92. Yutoku Yakuhin Description and Business Overview
Table 93. Yutoku Yakuhin Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 94. Yutoku Yakuhin Ketoprofen Transdermal Patch Product
Table 95. Yutoku Yakuhin Recent Developments/Updates
Table 96. Nichi-Iko Pharmaceutical Company Information
Table 97. Nichi-Iko Pharmaceutical Description and Business Overview
Table 98. Nichi-Iko Pharmaceutical Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 99. Nichi-Iko Pharmaceutical Ketoprofen Transdermal Patch Product
Table 100. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 101. Abiogen Pharma Company Information
Table 102. Abiogen Pharma Description and Business Overview
Table 103. Abiogen Pharma Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 104. Abiogen Pharma Ketoprofen Transdermal Patch Product
Table 105. Abiogen Pharma Recent Developments/Updates
Table 106. Sanwa Kagaku Kenkyusho Company Information
Table 107. Sanwa Kagaku Kenkyusho Description and Business Overview
Table 108. Sanwa Kagaku Kenkyusho Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 109. Sanwa Kagaku Kenkyusho Ketoprofen Transdermal Patch Product
Table 110. Sanwa Kagaku Kenkyusho Recent Developments/Updates
Table 111. Wooshin Medics Company Information
Table 112. Wooshin Medics Description and Business Overview
Table 113. Wooshin Medics Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 114. Wooshin Medics Ketoprofen Transdermal Patch Product
Table 115. Wooshin Medics Recent Developments/Updates
Table 116. Jeil Pharmaceutical Company Information
Table 117. Jeil Pharmaceutical Description and Business Overview
Table 118. Jeil Pharmaceutical Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 119. Jeil Pharmaceutical Ketoprofen Transdermal Patch Product
Table 120. Jeil Pharmaceutical Recent Developments/Updates
Table 121. Emcure Pharmaceuticals Company Information
Table 122. Emcure Pharmaceuticals Description and Business Overview
Table 123. Emcure Pharmaceuticals Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 124. Emcure Pharmaceuticals Ketoprofen Transdermal Patch Product
Table 125. Emcure Pharmaceuticals Recent Developments/Updates
Table 126. Towa Pharmaceutical Company Information
Table 127. Towa Pharmaceutical Description and Business Overview
Table 128. Towa Pharmaceutical Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 129. Towa Pharmaceutical Ketoprofen Transdermal Patch Product
Table 130. Towa Pharmaceutical Recent Developments/Updates
Table 131. Nihon Generic Company Information
Table 132. Nihon Generic Description and Business Overview
Table 133. Nihon Generic Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 134. Nihon Generic Ketoprofen Transdermal Patch Product
Table 135. Nihon Generic Recent Developments/Updates
Table 136. Guizhou Liansheng Pharmaceutical Company Information
Table 137. Guizhou Liansheng Pharmaceutical Description and Business Overview
Table 138. Guizhou Liansheng Pharmaceutical Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 139. Guizhou Liansheng Pharmaceutical Ketoprofen Transdermal Patch Product
Table 140. Guizhou Liansheng Pharmaceutical Recent Developments/Updates
Table 141. Jiudian Pharmaceutical Company Information
Table 142. Jiudian Pharmaceutical Description and Business Overview
Table 143. Jiudian Pharmaceutical Ketoprofen Transdermal Patch Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 144. Jiudian Pharmaceutical Ketoprofen Transdermal Patch Product
Table 145. Jiudian Pharmaceutical Recent Developments/Updates
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Ketoprofen Transdermal Patch Distributors List
Table 149. Ketoprofen Transdermal Patch Customers List
Table 150. Ketoprofen Transdermal Patch Market Trends
Table 151. Ketoprofen Transdermal Patch Market Drivers
Table 152. Ketoprofen Transdermal Patch Market Challenges
Table 153. Ketoprofen Transdermal Patch Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
Table 157. Authors List of This Report
List of Figures
Figure 1. Product Picture of Ketoprofen Transdermal Patch
Figure 2. Global Ketoprofen Transdermal Patch Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Ketoprofen Transdermal Patch Market Share by Type: 2024 & 2031
Figure 4. Hydrogel Patch Product Picture
Figure 5. Polymer Matrix Controlled-Release Patch Product Picture
Figure 6. Self-Adhesive Nonwoven Patch Product Picture
Figure 7. Global Ketoprofen Transdermal Patch Market Value by Prescription, (US$ Million) & (2020-2031)
Figure 8. Global Ketoprofen Transdermal Patch Market Share by Prescription: 2024 VS 2031
Figure 9. Rx Product Picture
Figure 10. OTC Product Picture
Figure 11. Global Ketoprofen Transdermal Patch Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Ketoprofen Transdermal Patch Market Share by Application: 2024 & 2031
Figure 13. Hospitals and Clinics
Figure 14. Retail Pharmacies
Figure 15. Online Pharmacies
Figure 16. Global Ketoprofen Transdermal Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Ketoprofen Transdermal Patch Market Size (2020-2031) & (US$ Million)
Figure 18. Global Ketoprofen Transdermal Patch Sales (2020-2031) & (K Dose)
Figure 19. Global Ketoprofen Transdermal Patch Average Price (US$/Dose) & (2020-2031)
Figure 20. Ketoprofen Transdermal Patch Report Years Considered
Figure 21. Ketoprofen Transdermal Patch Sales Share by Manufacturers in 2024
Figure 22. Global Ketoprofen Transdermal Patch Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Ketoprofen Transdermal Patch Players: Market Share by Revenue in Ketoprofen Transdermal Patch in 2024
Figure 24. Ketoprofen Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Ketoprofen Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Ketoprofen Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 27. North America Ketoprofen Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 28. United States Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Ketoprofen Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 31. Europe Ketoprofen Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 32. Germany Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Ketoprofen Transdermal Patch Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Ketoprofen Transdermal Patch Revenue Market Share by Region (2020-2031)
Figure 39. China Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Ketoprofen Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 47. Latin America Ketoprofen Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Colombia Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Ketoprofen Transdermal Patch Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Ketoprofen Transdermal Patch Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Ketoprofen Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Ketoprofen Transdermal Patch by Type (2020-2031)
Figure 58. Global Revenue Market Share of Ketoprofen Transdermal Patch by Type (2020-2031)
Figure 59. Global Ketoprofen Transdermal Patch Price (US$/Dose) by Type (2020-2031)
Figure 60. Global Sales Market Share of Ketoprofen Transdermal Patch by Application (2020-2031)
Figure 61. Global Revenue Market Share of Ketoprofen Transdermal Patch by Application (2020-2031)
Figure 62. Global Ketoprofen Transdermal Patch Price (US$/Dose) by Application (2020-2031)
Figure 63. Ketoprofen Transdermal Patch Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
